Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Lilly has already filed regulatory applications in the United States, the EU and several other countries seeking approval for orforglipron in obesity
Therefore, it is generally contraindicated in individuals with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Chronic kidney disease (CKD), which frequently coexists with Type 2 diabetes, is another illness for which Farxiga is licensed to help protect the kidneys
A SURMOUNT-1 post-hoc analysis of 2,542 women, published in Obesity in 2025, found perimenopausal women on tirzepatide lost 23% of body weight against 3% on placebo, almost identical to the premenopausal result
It features 3 ingredients that have been clinically proven to lower thyroid antibodies: nigella sativa powder, myo-inositol, and selenium
Identify your maintenance floor
